# FDA Inspection 1233914 - Octapharma Plasma, Inc. - March 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/f1193bda-b502-4076-a330-80bb2378ef4e
Source feed: FDA_Inspections

> FDA Inspection 1233914 for Octapharma Plasma, Inc. on March 22, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1233914
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2024-03-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1088733 - 2019-05-02](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/062bdd4a-9507-459d-93fd-d7679a32e191)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/4c957300-d2bd-437e-acf8-5b0132c63267

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d